Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
GSK
GSK
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
GSK News
GSK Reports Positive Phase III Results for Hepatitis B Treatment Bepirovirsen
2d ago
NASDAQ.COM
Regulatory Approvals and Collaborations in Biotech Sector
1d ago
NASDAQ.COM
GSK's Antisense Drug Shows Promise in Hepatitis B Trials
2d ago
seekingalpha
Eli Lilly Returns to Vaccine Market with $4 Billion Acquisition of Three Companies
3d ago
Newsfilter
Volatility in UK Assets Amid Political Turmoil and Investment Opportunities
May 21 2026
CNBC
WHO Warns of Potential Worsening of Ebola Outbreak
May 20 2026
seekingalpha
FENI Stock Price Analysis and ETF Dynamics
May 19 2026
NASDAQ.COM
GT Biopharma Doses First Patient in GTB-5550 Clinical Trial
May 18 2026
Newsfilter
Bristol Myers Squibb Partners with Hengrui Pharma for Drug Development
May 15 2026
CNBC
GSK Launches Final £2 Billion Share Buyback Tranche
May 11 2026
NASDAQ.COM
Halozyme and GSK Reach Drug Delivery Technology Licensing Agreement
May 07 2026
seekingalpha
HALOZYME AND GSK ENTER INTO GLOBAL PARTNERSHIP AND LICENSE DEAL TO ADVANCE SUBCUTANEOUS FORMULATIONS FOR SEVERAL PROMISING CANCER TARGETS
May 07 2026
moomoo
FDA Blocks Publication of Vaccine Safety Studies Amid Controversy
May 05 2026
CNBC
GSK Completes $950 Million Acquisition of 35Pharma to Enhance Pipeline
May 03 2026
Yahoo Finance
FDA Appoints New Acting Director for Biologics Center
May 01 2026
seekingalpha
Alector Discontinues Mid-Stage Alzheimer’s Trial for Latozinemab
Apr 30 2026
seekingalpha
Show More News
